Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
Exagen Inc. (NASDAQ:XGN) Reports Record 2025 Revenue and Provides 2026 Outlook
Exagen Inc. (NASDAQ:XGN) reported record 2025 annual revenue of $66.58 million, a 20% increase over the previous year, driven by higher test volumes and improved pricing for its AVISE CTD test. Despite missing Q4 2025 revenue and EPS estimates, the company highlighted significant operational achievements and a strengthened financial position, ending the year with $32.2 million in cash. Exagen provided 2026 revenue guidance of $70 million to $73 million, slightly below analyst consensus, as it continues its path toward cash flow positivity.